You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Severe combined immunodeficiency due to DCLRE1C deficiency, look for clinical trials, and connect with others living with it — all in one place.
Open the full Severe combined immunodeficiency due to DCLRE1C deficiency hub →Severe combined immunodeficiency due to DCLRE1C deficiency is a rare condition. Also known as SCID T-B-NK+ due to ARTEMIS deficiency, SCID T-B-NK+ due to DCLRE1C deficiency, SCID T-B-NK+, Athabascan type, SCID T-B-NK+, Athabaskan type, T-B-NK+ severe combined immunodeficiency due to ARTEMIS deficiency, T-B-NK+ severe combined immunodeficiency, Athabascan type, T-B-NK+ severe combined immunodeficiency, Athabaskan type. Tomeko brings together the specialists, research, clinical trials, treatments and community for Severe combined immunodeficiency due to DCLRE1C deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:275 · OMIM 602450 · ICD-10 D81.1 · GARD 0009987
Start by learning the basics from an authoritative source, find a specialist or center that sees Severe combined immunodeficiency due to DCLRE1C deficiency, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Severe combined immunodeficiency due to DCLRE1C deficiency, filtered to your area.
Tomeko shows live, recruiting studies for Severe combined immunodeficiency due to DCLRE1C deficiency from ClinicalTrials.gov on the hub.